Replicate Crossover Study Design
Replicate Crossover Study Design is a longitudinal clinical trial methodology in bioequivalence research wherein each participant receives multiple administrations of both test and reference formulations in a randomized sequence across two or more treatment periods, enabling the separate estimation of within-subject variability for test and reference products through repeated measurements on the same subjects.
492
Publications
21.2K
Citations
2.6K
Authors
893
Institutions
Publications per year
2017–2026
119
Variants
Replicate Crossover Design
492
1–5 of 492
2.6K
7
h-index
6
h-index
5
h-index
4
h-index
4
h-index
1–5 of 2.6K
893

University of Toronto
Toronto, Canada
8 h-index
26 publications
1.3K citations

Seoul National University Hospital
Seoul, South Korea
8 h-index
61 publications
1.4K citations
University of Florida
Gainesville, United States
7 h-index
33 publications
1.2K citations
Kansas State University
Manhattan, United States
6 h-index
20 publications
826 citations
University of Guelph
Guelph, Canada
6 h-index
15 publications
481 citations

Aarhus University
Aarhus, Denmark
6 h-index
16 publications
470 citations
The Ohio State University
Columbus, United States
5 h-index
24 publications
988 citations
Purdue University West Lafayette
West Lafayette, United States
5 h-index
14 publications
585 citations
1–8 of 893
43 publications · 1.2K citations
21
h-index
23 publications · 847 citations
16
h-index
AJVR · 11 publications · 485 citations
11
h-index
Repository · 12 publications · 536 citations
10
h-index
AJCN · 8 publications · 671 citations
8
h-index
1–5